{"altmetric_id":4688423,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Radboud University"],"first_seen_on":"2015-10-28T12:47:07+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1427290553,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02228954?term=kidney+cancer&amp%3Blup_s=02\/23\/2015&amp%3Blup_d=30","http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02228954?term=kidney+cancer&lup_s=08%2F07%2F2014&lup_d=30"],"nct_id":"NCT02228954","pubdate":"2014-08-26T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4922060,"mean":5.8458573235324,"rank":4116989,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":4922060,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":186360,"mean":9.9432198713238,"rank":145790,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":186360,"percentile":1},"this_journal":{"total_number_of_other_articles":12891,"mean":4.2595868114818,"rank":11076,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":12891,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":672,"mean":4.6152220566319,"rank":555,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":672,"percentile":1}}},"demographics":[],"counts":{"total":{"posts_count":2},"facebook":{"unique_users_count":1,"unique_users":["171856639526282"],"posts_count":2}},"posts":{"facebook":[{"title":"IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)","url":"https:\/\/www.facebook.com\/171856639526282\/posts\/844727372239202","license":"public","citation_ids":[4688423],"posted_on":"2014-09-06T21:48:48+00:00","summary":"Conditions: Clear-cell Metastatic Renal Cell Carcinoma; Kidney Neoplasms\nIntervention: Procedure: Molecular imaging\nSponsors: Radboud University; KWF-Alpe d'HuZes\nNot yet recruiting - verified August 2014","author":{"name":"Kidney Cancer Clinical Trials","url":"https:\/\/www.facebook.com\/171856639526282","facebook_wall_name":"Kidney Cancer Clinical Trials","image":"https:\/\/graph.facebook.com\/171856639526282\/picture","id_on_source":"171856639526282"}},{"title":"IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=967862083259063&id=171856639526282","license":"public","citation_ids":[4688423],"posted_on":"2015-03-25T13:35:53+00:00","summary":"Conditions: Clear-cell Metastatic Renal Cell Carcinoma; Kidney Neoplasms\nIntervention: Procedure: Molecular imaging\nSponsors: Radboud University; KWF-Alpe d'HuZes\nRecruiting - verified March 2015","author":{"name":"Kidney Cancer Clinical Trials","url":"https:\/\/www.facebook.com\/171856639526282","facebook_wall_name":"Kidney Cancer Clinical Trials","image":"https:\/\/graph.facebook.com\/171856639526282\/picture","id_on_source":"171856639526282"}}]}}